Consolidated Statement of Cash Flows - USD ($)
$ in Thousands |
9 Months Ended |
Sep. 30, 2016 |
Sep. 30, 2015 |
| Statement of Cash Flows [Abstract] |
|
|
| Net income (loss) |
$ 52,944
|
$ (33,787)
|
| Adjustments to reconcile net income (loss) to cash provided by operating activities: |
|
|
| Amortization and depreciation |
18,743
|
31,162
|
| Impairment of IPR&D assets |
1,300
|
0
|
| Provision for losses on accounts receivable |
87
|
0
|
| Provision for inventory reserves |
9
|
0
|
| Amortization of investment premiums, net |
95
|
261
|
| Amortization of inventory step-up |
2,989
|
14,244
|
| Stock-based compensation |
16,475
|
15,052
|
| Deferred income taxes |
215
|
(1,709)
|
| (Gain) loss on disposal of property and equipment |
48
|
(39)
|
| (Gain) loss on sale of available-for-sale securities |
(50)
|
21
|
| Change in fair value of contingent consideration |
209
|
(123)
|
| Impairment of long-lived assets |
0
|
153
|
| Impairment of lease |
0
|
6,161
|
| Loss on foreign currency |
66
|
0
|
| Excess tax benefits on stock based awards |
(6,042)
|
0
|
| Changes in operating assets and liabilities: |
|
|
| Accounts receivable |
(7,360)
|
5,971
|
| Inventory |
6,955
|
(10,069)
|
| Prepaid expenses and other assets |
(365)
|
700
|
| Accounts payable, accrued expenses and other current liabilities |
2,497
|
(8,822)
|
| Accrued compensation |
3,357
|
4,845
|
| Deferred revenue and deferred profit |
1,228
|
526
|
| Accrued price protection liability |
(2,914)
|
6,200
|
| Other long-term liabilities |
(772)
|
(264)
|
| Net cash provided by operating activities |
89,714
|
30,483
|
| Investing Activities |
|
|
| Purchases of property and equipment |
(6,828)
|
(1,480)
|
| Purchases of intangible assets |
(390)
|
(100)
|
| Cash used in acquisition, net of cash acquired |
(101,000)
|
(3,615)
|
| Purchases of available-for-sale securities |
(80,263)
|
(45,680)
|
| Maturities of available-for-sale securities |
88,711
|
57,508
|
| Net cash provided by (used in) investing activities |
(99,770)
|
6,633
|
| Financing Activities |
|
|
| Repurchases of common stock |
(3)
|
(101)
|
| Net proceeds from issuance of common stock |
4,450
|
6,346
|
| Minimum tax withholding paid on behalf of employees for restricted stock units |
(6,184)
|
(4,528)
|
| Equity issuance costs |
0
|
(705)
|
| Net cash provided by (used in) financing activities |
(1,737)
|
1,012
|
| Effect of exchange rate changes on cash and cash equivalents |
(87)
|
(675)
|
| Increase (decrease) in cash and cash equivalents |
(11,880)
|
37,453
|
| Cash and cash equivalents at beginning of period |
67,956
|
20,696
|
| Cash and cash equivalents at end of period |
56,076
|
58,149
|
| Supplemental disclosures of cash flow information: |
|
|
| Cash paid for income taxes |
1,483
|
0
|
| Issuance of restricted stock units to Physpeed continuing employees |
578
|
0
|
| Issuance of accrued share-based bonus plan |
$ 7,649
|
$ 5,459
|